The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy.
暂无分享,去创建一个
J. Trubiano | S. Vogrin | N. Holmes | M. Slavin | G. Drewett | M. Rose | A. Douglas | K. Chua
[1] E. Phillips,et al. The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] E. Phillips,et al. Oral Challenge with Trimethoprim-Sulfamethoxazole in Patients with "Sulfa" Antibiotic Allergy. , 2020, The journal of allergy and clinical immunology. In practice.
[3] S. Knowles,et al. Sulfonamide Hypersensitivity: Fact and Fiction. , 2019, The journal of allergy and clinical immunology. In practice.
[4] E. Phillips,et al. Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Host. , 2019, The journal of allergy and clinical immunology. In practice.
[5] E. Phillips,et al. Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] E. Macy,et al. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. , 2009, The American journal of medicine.
[7] C. Giffen,et al. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. , 2001, The Journal of infectious diseases.